Colon carcinoma
MONDO:0002032A carcinoma that arises from epithelial cells of the colon
Also known as: colon cancer, carcinoma of colon, carcinoma of the colon, colon carcinoma, colonic carcinoma
3232 clinical trials for this condition and its sub-types, 277 tagged with Colon carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Colon carcinoma
-
Colon adenocarcinoma 90 trials · 121 incl. sub-types
5 sub-types
- Cecum adenocarcinoma 0 trials · 31 incl. sub-types Sub-types →
- Colon mucinous adenocarcinoma 2 trials · 21 incl. sub-types Sub-types →
- Colon signet ring cell adenocarcinoma 2 trials
- Colon medullary carcinoma 0 trials
- Submucosal invasive colon adenocarcinoma 0 trials
-
Cecum carcinoma 1 trial · 43 incl. sub-types
3 sub-types
- Appendix carcinoma 11 trials · 42 incl. sub-types Sub-types →
- Cecum adenocarcinoma 0 trials · 31 incl. sub-types Sub-types →
- Carcinoma in situ of cecum 0 trials Sub-types →
-
Rectosigmoid carcinoma 5 trials
-
Colon carcinoma in situ 3 trials
1 sub-type
- Carcinoma in situ of cecum 0 trials Sub-types →
-
Squamous cell carcinoma of colon 0 trials
1 sub-type
- Adenosquamous colon carcinoma 0 trials
Most studied deeper sub-types
-
Experimental cell therapy targets tough cancers, but trial ends early
Disease control Stopped earlyThis early-phase trial tested a new approach: taking a patient's own white blood cells, genetically modifying them in the lab to recognize a specific cancer mutation (KRAS G12D), and infusing them back to attack tumors. The study enrolled only 5 adults with advanced gastrointesti…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Experimental cancer drug AUR106 tested in humans for first time
Disease control Stopped earlyThis early-stage trial tested an experimental drug called AUR106 in 21 adults with advanced solid tumors (lung, stomach, bladder, kidney, colon, or esophageal cancer) that had come back or spread. The main goals were to check safety, find the right dose, and see how the drug move…
Phase 1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New pill for Hard-to-Treat cancers shows early promise in small study
Disease control Stopped earlyThis early-stage study tested a new oral drug, ATX-559, in 17 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose and check for side effects. The study was terminated early, so results are limited.
Phase 1 • Sponsor: Accent Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New cancer drug tested in people with advanced tumors
Disease control Stopped earlyThis early study tested a new drug called PHN-010 in 26 people with advanced cancers like lung, colon, and ovarian cancer. The drug is designed to deliver a powerful treatment directly to cancer cells. The main goals were to check safety and find the right dose, but the study was…
Phase 1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC